Healthcare provider profile · identity verified

Bryan Tolle, D.O.

Family Practice · LA GRANDE, OR · NPI 1275878894

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	494	138
Levothyroxine Sodium	Levothyroxine Sodium	363	98
Lisinopril	Lisinopril	357	102
Amlodipine Besylate	Amlodipine Besylate	235	68
Losartan Potassium	Losartan Potassium	220	66
Omeprazole	Omeprazole	211	60
Metoprolol Succinate	Metoprolol Succinate	192	55
Tamsulosin Hcl	Tamsulosin Hcl	163	46
Potassium Chloride	Potassium Chloride	153	52
Gabapentin	Gabapentin	145	36
Furosemide	Furosemide	140	49
Albuterol Sulfate Hfa	Albuterol Sulfate	137	40
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	112	33
Metformin Hcl Er	Metformin Hcl	110	31
Pantoprazole Sodium	Pantoprazole Sodium	102	24
Sertraline Hcl	Sertraline Hcl	102	21
Rosuvastatin Calcium	Rosuvastatin Calcium	94	36
Eliquis	Apixaban	89	23
Jardiance	Empagliflozin	81	22
Hydrochlorothiazide	Hydrochlorothiazide	77	20
Trazodone Hcl	Trazodone Hcl	77	18
Metformin Hcl	Metformin Hcl	72	25
Allopurinol	Allopurinol	70	20
Metoprolol Tartrate	Metoprolol Tartrate	69	22
Clopidogrel	Clopidogrel Bisulfate	64	19
Warfarin Sodium	Warfarin Sodium	64	19
Spironolactone	Spironolactone	63	23
Buprenorphine Hcl	Buprenorphine Hcl	58	suppressed
Famotidine	Famotidine	56	14
Tizanidine Hcl	Tizanidine Hcl	55	23
Farxiga	Dapagliflozin Propanediol	52	13
Hydroxyzine Hcl	Hydroxyzine Hcl	52	17
Zolpidem Tartrate	Zolpidem Tartrate	52	13
Synthroid	Levothyroxine Sodium	51	suppressed
Ventolin Hfa	Albuterol Sulfate	46	14
Alendronate Sodium	Alendronate Sodium	45	12
Fluticasone Propionate	Fluticasone Propionate	44	16
Chlorthalidone	Chlorthalidone	43	16
Lovastatin	Lovastatin	43	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	13
Meloxicam	Meloxicam	40	suppressed
Ozempic	Semaglutide	40	13
Oxycodone Hcl	Oxycodone Hcl	39	11
Simvastatin	Simvastatin	39	13
Clonazepam	Clonazepam	38	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Duloxetine Hcl	Duloxetine Hcl	36	14
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Xarelto	Rivaroxaban	35	suppressed
Carvedilol	Carvedilol	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	12
Finasteride	Finasteride	33	suppressed
Ramipril	Ramipril	32	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Mirtazapine	Mirtazapine	31	suppressed
Atenolol	Atenolol	30	suppressed
Morphine Sulfate Er	Morphine Sulfate	29	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	29	suppressed
Montelukast Sodium	Montelukast Sodium	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	26	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Olanzapine	Olanzapine	26	suppressed
Ramelteon	Ramelteon	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Lorazepam	Lorazepam	25	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	24	suppressed
Telmisartan	Telmisartan	24	suppressed
Azithromycin	Azithromycin	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Ondansetron Odt	Ondansetron	22	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Glipizide	Glipizide	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Modafinil	Modafinil	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Scopolamine	Scopolamine	16	suppressed
Baclofen	Baclofen	15	suppressed
Valsartan	Valsartan	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Nitroglycerin	Nitroglycerin	14	12
Torsemide	Torsemide	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Indomethacin	Indomethacin	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Estradiol	Estradiol	12	suppressed
Naproxen	Naproxen	12	suppressed
Nystatin	Nystatin	12	suppressed
Prednisone	Prednisone	12	11
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	12	suppressed
Tramadol Hcl	Tramadol Hcl	12	suppressed
Buprenorphine	Buprenorphine	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error